Nxera Pharma Co (TSE:4565) Cyclically Adjusted Book per Share: 円700.41 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4565 Nxera Pharma Co Ltd TSE:4565
74 GF Score
Price 円1,103.00
GF Value 円853.83
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Nxera Pharma Co Cyclically Adjusted Book per Share?

Nxera Pharma Co TSE:4565 -2.65% 74 Cyclically Adjusted Book per Share is 円700.41 as of Jun. 2026. GuruFocus rates TSE:4565 with a GF Score™ of 74/100 and a GF Value™ of 円853.83 (Modestly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nxera Pharma Co's adjusted book value per share for the three months ended in Jun. 2026 was 円709.191. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円700.41 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Nxera Pharma Co's average Cyclically Adjusted Book Growth Rate was 5.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Nxera Pharma Co was 15.20% per year. The lowest was 11.10% per year. And the median was 14.20% per year.

As of today (2026-08-23), Nxera Pharma Co's current stock price is 円1103.00. Nxera Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was 円700.41. Nxera Pharma Co's Cyclically Adjusted PB Ratio of today is 1.57.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nxera Pharma Co was 11.09. The lowest was 1.11. And the median was 3.89.


Nxera Pharma Co  (TSE:4565) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nxera Pharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1103.00/700.41
=1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nxera Pharma Co was 11.09. The lowest was 1.11. And the median was 3.89.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nxera Pharma Co Cyclically Adjusted Book per Share Related Terms


Nxera Pharma Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Cyclically Adjusted Book per Share Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 426.18 498.18 569.29 636.93 683.81

Nxera Pharma Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 663.77 673.64 683.81 689.71 700.41

TSE:4565 vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Cyclically Adjusted PB Ratio falls into.


TSE:4565
74GF Score
Nxera Pharma Co Ltd TSE:4565
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nxera Pharma Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=709.191/113.6000*113.6000
=709.191

Current CPI (Jun. 2026) = 113.6000.

Nxera Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 404.261 98.000 468.613
201612 449.711 98.400 519.179
201703 419.035 98.100 485.243
201706 449.278 98.500 518.152
201709 457.744 98.800 526.313
201712 664.511 99.400 759.441
201803 641.328 99.200 734.424
201806 609.617 99.200 698.110
201809 597.906 99.900 679.901
201812 544.901 99.700 620.870
201903 571.240 99.700 650.881
201906 542.278 99.800 617.262
201909 550.972 100.100 625.279
201912 584.835 100.500 661.067
202003 547.527 100.300 620.130
202006 529.811 99.900 602.468
202009 598.491 99.900 680.566
202012 649.921 99.300 743.515
202103 680.651 99.900 773.994
202106 685.115 99.500 782.202
202109 659.646 100.100 748.609
202112 704.973 100.100 800.049
202203 693.788 101.100 779.568
202206 688.036 101.800 767.789
202209 679.919 103.100 749.164
202212 707.201 104.100 771.739
202303 710.594 104.400 773.213
202306 761.043 105.200 821.811
202309 703.872 106.200 752.918
202312 746.931 106.800 794.488
202403 736.601 107.200 780.577
202406 767.280 108.200 805.573
202409 753.718 108.900 786.248
202412 762.149 110.700 782.115
202503 746.054 111.100 762.842
202506 727.786 111.700 740.166
202509 725.521 112.000 735.886
202512 674.037 113.000 677.616
202603 703.752 112.700 709.372
202606 709.191 113.600 709.191

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円700.41 mean?
Nxera Pharma Co (TSE:4565) has a Cyclically Adjusted Book per Share of 円700.41 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Cyclically Adjusted Book per Share too high?
Nxera Pharma Co's current Cyclically Adjusted Book per Share is 円700.41. Overall, Nxera Pharma Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Nxera Pharma Co's Cyclically Adjusted Book per Share of 円700.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Cyclically Adjusted Book per Share is 円700.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Nxera Pharma Co (TSE:4565) is currently considered Modestly Overvalued. The stock's GF Value™ is 円853.83, compared to a current price of 円1,103.00 — trading 29.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is 円700.41. Nxera Pharma Co's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nxera Pharma Co (TSE:4565), the current Cyclically Adjusted Book per Share is 円700.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be overvalued. The current stock price of 円1,103.00 is trading 29.2% above its estimated GF Value™ of 円853.83. GuruFocus considers Nxera Pharma Co to be Modestly Overvalued.

Key valuation signals for TSE:4565:

  • Cyclically Adjusted Book per Share: 円700.41
  • GF Value™: 円853.83 vs. price of 円1,103.00 (29.2% above fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
74GF Score

Get the complete analysis for TSE:4565

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,103.00
Price
円853.83
GF Value